A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

Eli Lilly LLY announced that its investigational oral, once-daily cholesterol-lowering drug muvalaplin reduced lipoprotein(a) ...

Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns.

Eli Lilly's muvalaplin Phase 2 trial showed significant Lp(a) reduction, meeting primary and secondary endpoints with ...

Since the discovery of statins and the Scandinavian Simvastatin Survival Study (4S) results three decades ago, remarkable advances have been made in the treatment of dyslipidaemia, a major risk factor ...

At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...

Older adults whose cholesterol levels fluctuate from year to year may face an increased risk for dementia and cognitive decline compared to people whose cholesterol levels remain more stable, new ...

First on her list is oats, which she believes are crucial for lowering cholesterol. She said: "I always stock my kitchen with oats, and typically have half a cup per day." "Not only are they high ...

She placed oats at the top of her list for cholesterol-lowering foods. She shared, "I always stock my kitchen with oats, and typically have half a cup per day." She highlighted their benefits: "Not ...

Cholesterol tests are well-established as an important part of a routine health screening – for adults. For young people, it's another story.

This would pave the way for more advanced and ethical drug discovery by reducing the need for animal testing. Head of the Collins BioMicrosystems Laboratory at the University of Melbourne ...